# HRD Status Reference Standard Based on WGS

> **NCT06490380** · — · COMPLETED · sponsor: **Lei Li** · enrollment: 100 (actual)

## Conditions studied

- Ovarian Cancer

## Interventions

- **DRUG:** PARPi

## Key facts

- **NCT ID:** NCT06490380
- **Lead sponsor:** Lei Li
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-30
- **Primary completion:** 2023-12-13
- **Final completion:** 2024-06-21
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2024-07-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06490380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06490380, "HRD Status Reference Standard Based on WGS". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06490380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*